Analysts review Tenax Therapeutics Inc’s rating

Daniel Torres

Tenax Therapeutics Inc’s filing revealed that its Chief Medical Officer Rich Stuart acquired Company’s shares for reported $25542.0 on Dec 09 ’25. In the deal valued at $10.22 per share,2,500 shares were bought. As a result of this transaction, Rich Stuart now holds 5,266 shares worth roughly $64877.12.

Then, Rich Stuart bought 2,500 shares, generating $25,250 in total proceeds. Upon buying the shares at $10.10, the Chief Medical Officer now owns 5,000 shares.

Before that, Rich Stuart bought 2,500 shares. Tenax Therapeutics Inc shares valued at $22,998 were divested by the Chief Medical Officer at a price of $9.20 per share. As a result of the transaction, Rich Stuart now holds 2,500 shares, worth roughly $30800.0.

Piper Sandler initiated its Tenax Therapeutics Inc [TENX] rating to an Overweight in a research note published on September 08, 2025; the price target was $20. A number of analysts have revised their coverage, including Leerink Partners’s analysts, who began to cover the stock in late October with a ‘”an Outperform”‘ rating. Guggenheim began covering TENX with “Buy” recommendation on October 14, 2024. William Blair started covering the stock on September 30, 2024. It rated TENX as “an Outperform”.

Price Performance Review of TENX

On Monday, Tenax Therapeutics Inc [NASDAQ:TENX] saw its stock jump 11.49% to $12.32. Over the last five days, the stock has lost -2.76%. Tenax Therapeutics Inc shares have risen nearly 99.03% since the year began. Nevertheless, the stocks have risen 1.07% over the past one year. While a 52-week high of $14.22 was reached on 01/05/26, a 52-week low of $4.63 was recorded on 01/02/26.

Levels Of Support And Resistance For TENX Stock

The 24-hour chart illustrates a support level at 11.44, which if violated will result in even more drops to 10.55. On the upside, there is a resistance level at 13.53. A further resistance level may holdings at 14.73.

How much short interest is there in Tenax Therapeutics Inc?

A steep rise in short interest was recorded in Tenax Therapeutics Inc stocks on 2025-12-15, dropping by -0.23 million shares to a total of 0.53 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-14 was 0.76 million shares. There was a decline of -42.77%, which implies that there is a negative sentiment for the stock.

Knox Daily
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.